Special Issue "The Pathogenesis and Prevention and Treatment of Coronary Heart Disease and Structural Heart Disease"
Deadline for manuscript submissions: 30 November 2023 | Viewed by 974
Interests: hemodynamics in the pathogenesis of coronary heart disease; biophysical mechanisms of thrombosis and thrombotic complications after device implantation in cardiovascular system; clinical trials and basic research for novel treatments of heart failure
Interests: basic research and disease maker identification in cardiovascular and metabolic diseases
Cardiovascular disease, especially coronary heart disease and structural heart disease, remains the leading cause of global mortality and morbidity and represents a major economic burden on health-care systems. Recently, a large number of clinical trials have emerged to demonstrate the benefit of new drugs and devices in treating these diseases. Furthermore, numerous basic studies also explored the mechanisms involving disease development in part. However, the major mechanisms and issues remain unknown.
With this Special Issue, we welcome clinical trials and mechanism studies of coronary heart diseases and structural heart disease. Furthermore, intervention and surgery are two main treatments of coronary heart disease and structural heart disease, and so part of this Special Issue will be also dedicated to research on these treatments, including — but not limited to — PCI, CABG, TAVR, SAVR, TEER, and TMVR.
We welcome original research articles reporting results from basic, clinical, and translational studies, as well as expert review articles that explore the mechanism, diagnosis, treatment, and the prediction of prognosis for coronary heart diseases and structural heart disease.
Dr. Junxia Zhang
Dr. Hongsong Zhang
Dr. Xiaofei Gao
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- coronary heart disease
- structural heart disease